These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26323412)

  • 21. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia.
    Fister P; Urh S; Karner A; Krzan M; Paro-Panjan D
    J Matern Fetal Neonatal Med; 2015; 28(17):2053-61. PubMed ID: 25316561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical excipient development: the need for preclinical guidance.
    Baldrick P
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.
    Nellis G; Metsvaht T; Varendi H; Lass J; Duncan J; Nunn AJ; Turner MA; Lutsar I
    Paediatr Drugs; 2016 Jun; 18(3):221-30. PubMed ID: 27099961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.
    Turner MA; Duncan JC; Shah U; Metsvaht T; Varendi H; Nellis G; Lutsar I; Yakkundi S; McElnay JC; Pandya H; Mulla H; Vaconsin P; Storme T; Rieutord A; Nunn AJ
    Adv Drug Deliv Rev; 2014 Jun; 73():89-101. PubMed ID: 24239480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Educational paper: do we need neonatal clinical pharmacologists?
    Allegaert K; Langhendries JP; van den Anker JN
    Eur J Pediatr; 2013 Apr; 172(4):429-35. PubMed ID: 22588521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
    Giacoia GP; Taylor-Zapata P; Mattison D
    Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric Safety of Polysorbates in Drug Formulations.
    Kriegel C; Festag M; Kishore RSK; Roethlisberger D; Schmitt G
    Children (Basel); 2019 Dec; 7(1):. PubMed ID: 31877624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
    Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
    Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research on medication use in the neonatal intensive care unit.
    Allegaert K; Simons S; Van Den Anker J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):343-353. PubMed ID: 30741041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
    Abrantes CG; Duarte D; Reis CP
    J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal clinical pharmacology.
    Allegaert K; van de Velde M; van den Anker J
    Paediatr Anaesth; 2014 Jan; 24(1):30-8. PubMed ID: 23617305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safe excipient exposure in neonates and small children - protocol for the SEEN project.
    Valeur KS; Hertel SA; Lundstrøm KE; Holst H
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug policy in Europe Research and funding in neonates: current challenges, future perspectives, new opportunities.
    Jacqz-Aigrain E
    Early Hum Dev; 2011 Mar; 87 Suppl 1():S27-30. PubMed ID: 21269785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical research in neonates and infants: Challenges and perspectives.
    Coppini R; Simons SHP; Mugelli A; Allegaert K
    Pharmacol Res; 2016 Jun; 108():80-87. PubMed ID: 27142783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use.
    Smits A; van den Anker JN; Allegaert K
    J Pharm Pharmacol; 2017 Apr; 69(4):350-360. PubMed ID: 27364566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicity of excipients--a Food and Drug Administration perspective.
    Osterberg RE; See NA
    Int J Toxicol; 2003; 22(5):377-80. PubMed ID: 14555410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving drug formulations for neonates: making a big difference in our smallest patients.
    Noel GJ; Van Den Anker JN; Lombardi D; Ward R
    J Pediatr; 2012 Nov; 161(5):947-9. PubMed ID: 23095694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.